A61K 49/0069
The agent being in a particular physical galenical form
Official title: {the agent being in a particular physical galenical form}
A61K49/0069 (The agent being in a particular physical galenical form) appears on 815 US grants and 1,442 published applications in this corpus.
Search patents in A61K- Granted patents
- 815
- Published applications
- 1,442
- Assignees
- 679
- Inventors
- 3,237
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 12 | 4 |
| 2002 | 6 | 9 |
| 2003 | 8 | 17 |
| 2004 | 4 | 16 |
| 2005 | 4 | 21 |
| 2006 | 6 | 11 |
| 2007 | 7 | 33 |
| 2008 | 2 | 37 |
| 2009 | 4 | 50 |
| 2010 | 7 | 51 |
| 2011 | 17 | 72 |
| 2012 | 25 | 46 |
| 2013 | 39 | 85 |
| 2014 | 39 | 70 |
| 2015 | 43 | 94 |
| 2016 | 55 | 83 |
| 2017 | 68 | 92 |
| 2018 | 61 | 91 |
| 2019 | 72 | 86 |
| 2020 | 62 | 99 |
| 2021 | 56 | 89 |
| 2022 | 44 | 65 |
| 2023 | 37 | 77 |
| 2024 | 39 | 55 |
| 2025 | 46 | 54 |
| 2026 | 29 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Method for treating cancerous tissue with a nanotherapeutic1 Sep 2026US 12,721,910 B2Imam Abdulrahman Bin Faisal University
- Methods for preparing nanotherapeutic compositions1 Sep 2026US 12,721,911 B2Imam Abdulrahman Bin Faisal University
- Functionalized silica nanorings, methods of making same, and uses thereof11 Aug 2026US 12,703,637 B2Cornell University
- Methods and materials for treating cancer8 Oct 2026US 2026/0306684 A1Mayo Foundation for Medical Education and Research
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Liposome Composition Comprising Farnesol and Method of Use Thereof for Treating Fungal Infection24 Sep 2026US 2026/0283957 A1
- Systems and methods for imaging animals24 Sep 2026US 2026/0284232 A1Arizona Board of Regents on Behalf of the University of Arizona
- Dual-modal tumor imaging using functionalized iron-oxide nanoparticles for mri and fluorescence imaging3 Sep 2026US 2026/0256952 A1University of South Florida
Most cited
By later US patents
- System for selective release of liposome encapsulated material via laser radiation291US 4,891,043 AThe Board of Trustees of the University of Illinois · 1990
- Liquid delivery compositions268US 5,780,044 AAtrix Laboratories, Inc. · 1998
- Liquid delivery compositions243US 5,744,153 AAtrix Laboratories, Inc. · 1998
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Devices and methods for monitoring drug therapy compliance214US 6,663,846 B12003